The Genomic Signatures of Linitis Plastica Signal the Entrance into a New Era: Novel Approaches for Diagnosis and Treatment
Abstract
1. Introduction
2. Methods
3. Molecular Background (Oncogenes, Drivers, Pathways)
4. Biomarkers
5. Novel Targets—Approaches
6. Role of Surgery
7. Discussion
8. Conclusions
Author Contributions
Funding
Conflicts of Interest
Abbreviations
References
- Fushida, S.; Kinoshita, J.; Oyama, K.; Fujimura, T.; Tsukada, T.; Yamaguchi, T.; Ninomiya, I.; Ohta, T. Multidisciplinary Therapy for Scirrhous Cancer: A Retrospective Analysis and Proposal of New Treatment Strategy. Cancer Manag. Res. 2018, 10, 3833–3839. [Google Scholar] [CrossRef]
- Kurata, A.; Yamada, M.; Ohno, S.-I.; Inoue, S.; Hashimoto, H.; Fujita, K.; Takanashi, M.; Kuroda, M. Expression Level of MicroRNA-200c Is Associated with Cell Morphology in Vitro and Histological Differentiation through Regulation of ZEB1/2 and E-Cadherin in Gastric Carcinoma. Oncol. Rep. 2018, 39, 91–100. [Google Scholar] [CrossRef]
- Liu, Z.; Hong, L.-L.; Zheng, J.-S.; Ling, Z.-N.; Zhang, Z.-L.; Qi, Y.-N.; Zhang, X.-Y.; Zhu, T.-Y.; Wang, J.-L.; Han, J.; et al. Comprehensive Transcriptomic Profiling and Mutational Landscape of Primary Gastric Linitis Plastica. Gastric Cancer 2023, 26, 203–219. [Google Scholar] [CrossRef]
- Chen, W.; Xu, L.; Chang, E.; Gowrishankar, G.; Ferrara, K.W.; Gambhir, S.S. Alternative Medicine: Therapeutic Effects on Gastric Original Signet Ring Carcinoma via Ascorbate and Combination with Sodium Alpha Lipoate. BMC Complement. Med. Ther. 2022, 22, 58. [Google Scholar] [CrossRef]
- Drubay, V.; Nuytens, F.; Renaud, F.; Adenis, A.; Eveno, C.; Piessen, G. Poorly Cohesive Cells Gastric Carcinoma Including Signet-Ring Cell Cancer: Updated Review of Definition, Classification and Therapeutic Management. World J. Gastrointest. Oncol. 2022, 14, 1406–1428. [Google Scholar] [CrossRef]
- Aujla, U.I.; Jabbar, S.; Atique, M. Gastric Linitis Plastica and Role of Endoscopic Ultrasound: An under-Recognised Diagnostic Modality. J. Pak. Med. Assoc. 2022, 72, 174–176. [Google Scholar] [CrossRef]
- Agnes, A.; Estrella, J.S.; Badgwell, B. The Significance of a Nineteenth Century Definition in the Era of Genomics: Linitis Plastica. World J. Surg. Oncol. 2017, 15, 123. [Google Scholar] [CrossRef][Green Version]
- Ikoma, N.; Agnes, A.; Chen, H.-C.; Wang, X.; Blum, M.M.; Das, P.; Minsky, B.; Estrella, J.S.; Mansfield, P.; Ajani, J.A.; et al. Linitis Plastica: A Distinct Type of Gastric Cancer. J. Gastrointest. Surg. 2020, 24, 1018–1025. [Google Scholar] [CrossRef]
- Huang, J.; Zhao, G.; Peng, Q.; Yi, X.; Ji, L.; Li, J.; Li, P.; Guan, Y.; Ge, J.; Chen, L.; et al. Analysis of Genomic and Immune Intratumor Heterogeneity in Linitis Plastica via Multiregional Exome and T-Cell Receptor Sequencing. Mol. Oncol. 2023, 17, 1531–1544. [Google Scholar] [CrossRef]
- Miki, Y.; Yashiro, M.; Moyano-Galceran, L.; Sugimoto, A.; Ohira, M.; Lehti, K. Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in Scirrhous Type Gastric Cancer. Front. Oncol. 2020, 10, 568557. [Google Scholar] [CrossRef]
- Kunitomo, A.; Misawa, K.; Ito, Y.; Ito, S.; Higaki, E.; Natsume, S.; Kinoshita, T.; Abe, T.; Komori, K.; Shimizu, Y. Limited Clinical Significance of Splenectomy and Splenic Hilar Lymph Node Dissection for Type 4 Gastric Cancer. J. Gastric Cancer 2021, 21, 392–402. [Google Scholar] [CrossRef] [PubMed]
- Ayub, A.; Naeem, B.; Perez, A.; Tyler, D.; Klimberg, V.S. Gastric Linitis Plastica: Clinical Characteristics and Outcomes from the National Cancer Database. Anticancer Res. 2023, 43, 1543–1548. [Google Scholar] [CrossRef] [PubMed]
- Thompson, R.J.; Ranaghan, L.; Kennedy, R.; Clements, W.; Carey, P.D.; Kennedy, J.A. Survival Following Operative Management of Gastric Linitis Plastica Compared with Non-Operative Management. Ann. R. Coll. Surg. Engl. 2017, 99, 228–232. [Google Scholar] [CrossRef] [PubMed]
- Kasai, S.; Kuwayama, N.; Motoo, Y.; Kawashima, A.; Matsumoto, K.; Yano, S.; Matsushima, K.; Yasumoto, K. Dual Blockade of MET and VEGFR2 Signaling Pathways as a Potential Therapeutic Maneuver for Peritoneal Carcinomatosis in Scirrhous Gastric Cancer. Biochem. Biophys. Res. Commun. 2022, 600, 80–86. [Google Scholar] [CrossRef]
- Baba, K.; Kitajima, Y.; Miyake, S.; Nakamura, J.; Wakiyama, K.; Sato, H.; Okuyama, K.; Kitagawa, H.; Tanaka, T.; Hiraki, M.; et al. Hypoxia-Induced ANGPTL4 Sustains Tumour Growth and Anoikis Resistance through Different Mechanisms in Scirrhous Gastric Cancer Cell Lines. Sci. Rep. 2017, 7, 11127. [Google Scholar] [CrossRef]
- Sera, T.; Sakuma, T.; Maruo, K.; Tsujio, G.; Yamamoto, Y.; Sugimoto, A.; Kushiyama, S.; Togano, S.; Kuroda, K.; Kasashima, H.; et al. Candidate Oncogenes, ARHGAP4, NOS3, and OR51B5, for the Development of Scirrhous-Type Gastric Cancer. Anticancer Res. 2022, 42, 5195–5203. [Google Scholar] [CrossRef]
- Hong, J.Y.; An, J.Y.; Lee, J.; Park, S.H.; Park, J.O.; Park, Y.S.; Lim, H.Y.; Kim, K.-M.; Kang, W.K.; Kim, S.T. Claudin 18.2 Expression in Various Tumor Types and Its Role as a Potential Target in Advanced Gastric Cancer. Transl. Cancer Res. 2020, 9, 3367–3374. [Google Scholar] [CrossRef]
- Miki, Y.; Yashiro, M.; Okuno, T.; Kuroda, K.; Togano, S.; Hirakawa, K.; Ohira, M. Clinico-Pathological Significance of Exosome Marker CD63 Expression on Cancer Cells and Stromal Cells in Gastric Cancer. PLoS ONE 2018, 13, e0202956. [Google Scholar] [CrossRef]
- Yashiro, M.; Hasegawa, T.; Yamamoto, Y.; Tsujio, G.; Nishimura, S.; Sera, T.; Sugimoto, A.; Kushiyama, S.; Kasashima, H.; Fukuoka, T.; et al. Asporin Expression on Stromal Cells and/or Cancer Cells Might Be a Useful Prognostic Marker in Patients with Diffuse-Type Gastric Cancer. Eur. Surg. Res. 2021, 62, 53–60. [Google Scholar] [CrossRef]
- Nishimura, S.; Yashiro, M.; Sera, T.; Yamamoto, Y.; Kushitani, Y.; Sugimoto, A.; Kushiyama, S.; Togano, S.; Kuroda, K.; Okuno, T.; et al. Serine Threonine Kinase 11/Liver Kinase B1 Mutation in Sporadic Scirrhous-Type Gastric Cancer Cells. Carcinogenesis 2020, 41, 1616–1623. [Google Scholar] [CrossRef]
- Sai, E.; Miwa, Y.; Takeyama, R.; Kojima, S.; Ueno, T.; Yashiro, M.; Seto, Y.; Mano, H. Identification of Candidates for Driver Oncogenes in Scirrhous-Type Gastric Cancer Cell Lines. Cancer Sci. 2019, 110, 2643–2651. [Google Scholar] [CrossRef] [PubMed]
- Jinushi, R.; Mizuide, M.; Tanisaka, Y.; Masuda, S.; Koizumi, K.; Sasaki, A.; Ishihara, Y.; Shionoya, K.; Sato, R.; Sugimoto, K.; et al. Efficacy for Diagnoses of Scirrhous Gastric Cancer and Safety of Endoscopic Ultrasound-Guided Fine-Needle Aspiration: A Systematic Review and Meta-Analysis. JGH Open 2023, 7, 403–409. [Google Scholar] [CrossRef]
- Takada, R.; Minaga, K.; Hara, A.; Otsuka, Y.; Omoto, S.; Kamata, K.; Yamao, K.; Takenaka, M.; Hagiwara, S.; Honjo, H.; et al. Diagnostic Value of EUS-Guided Fine-Needle Aspiration Biopsy for Gastric Linitis Plastica with Negative Endoscopic Biopsy. J. Clin. Med. 2021, 10, 3716. [Google Scholar] [CrossRef]
- Irino, T.; Sano, T.; Hiki, N.; Ohashi, M.; Nunobe, S.; Kumagai, K.; Ida, S.; Yamaguchi, T. Diagnostic Staging Laparoscopy in Gastric Cancer: A Prospective Cohort at a Cancer Institute in Japan. Surg. Endosc. 2018, 32, 268–275. [Google Scholar] [CrossRef] [PubMed]
- Naito, Y.; Sakamoto, N.; Oue, N.; Yashiro, M.; Sentani, K.; Yanagihara, K.; Hirakawa, K.; Yasui, W. MicroRNA-143 Regulates Collagen Type III Expression in Stromal Fibroblasts of Scirrhous Type Gastric Cancer. Cancer Sci. 2014, 105, 228–235. [Google Scholar] [CrossRef]
- Li, Q.; Li, B.; Li, Q.; Wei, S.; He, Z.; Huang, X.; Wang, L.; Xia, Y.; Xu, Z.; Li, Z.; et al. Exosomal MiR-21-5p Derived from Gastric Cancer Promotes Peritoneal Metastasis via Mesothelial-to-Mesenchymal Transition. Cell Death Dis. 2018, 9, 854. [Google Scholar] [CrossRef]
- Miki, Y.; Yashiro, M.; Okuno, T.; Kitayama, K.; Masuda, G.; Hirakawa, K.; Ohira, M. CD9-Positive Exosomes from Cancer-Associated Fibroblasts Stimulate the Migration Ability of Scirrhous-Type Gastric Cancer Cells. Br. J. Cancer 2018, 118, 867–877. [Google Scholar] [CrossRef]
- Pernot, S.; Terme, M.; Radosevic-Robin, N.; Castan, F.; Badoual, C.; Marcheteau, E.; Penault-Llorca, F.; Bouche, O.; Bennouna, J.; Francois, E.; et al. Infiltrating and Peripheral Immune Cell Analysis in Advanced Gastric Cancer According to the Lauren Classification and Its Prognostic Significance. Gastric Cancer 2020, 23, 73–81. [Google Scholar] [CrossRef]
- Saito, R.; Maruyama, S.; Kawaguchi, Y.; Akaike, H.; Shimizu, H.; Furuya, S.; Kawaida, H.; Ichikawa, D. MiR-99a-5p as Possible Diagnostic and Prognostic Marker in Patients With Gastric Cancer. J. Surg. Res. 2020, 250, 193–199. [Google Scholar] [CrossRef]
- Oue, N.; Sentani, K.; Sakamoto, N.; Uraoka, N.; Yasui, W. Molecular Carcinogenesis of Gastric Cancer: Lauren Classification, Mucin Phenotype Expression, and Cancer Stem Cells. Int. J. Clin. Oncol. 2019, 24, 771–778. [Google Scholar] [CrossRef]
- Sahin, U.; Türeci, Ö.; Manikhas, G.; Lordick, F.; Rusyn, A.; Vynnychenko, I.; Dudov, A.; Bazin, I.; Bondarenko, I.; Melichar, B.; et al. FAST: A Randomised Phase II Study of Zolbetuximab (IMAB362) plus EOX versus EOX Alone for First-Line Treatment of Advanced CLDN18.2-Positive Gastric and Gastro-Oesophageal Adenocarcinoma. Ann. Oncol. 2021, 32, 609–619. [Google Scholar] [CrossRef] [PubMed]
- Sahin, U.; Schuler, M.; Richly, H.; Bauer, S.; Krilova, A.; Dechow, T.; Jerling, M.; Utsch, M.; Rohde, C.; Dhaene, K.; et al. A Phase I Dose-Escalation Study of IMAB362 (Zolbetuximab) in Patients with Advanced Gastric and Gastro-Oesophageal Junction Cancer. Eur. J. Cancer 2018, 100, 17–26. [Google Scholar] [CrossRef] [PubMed]
- Chen, X.; Zhi, Y.; Lin, Z.; Ma, J.; Mou, W.; Yu, J. Prognosis Prediction Model for a Special Entity of Gastric Cancer, Linitis Plastica. J. Gastrointest. Oncol. 2021, 12, 307–327. [Google Scholar] [CrossRef] [PubMed]
- Sugawara, K.; Iwai, M.; Yajima, S.; Tanaka, M.; Yanagihara, K.; Seto, Y.; Todo, T. Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer. Mol. Ther. Oncolytics 2020, 17, 205–215. [Google Scholar] [CrossRef]
- Pedrazzani, C.; Marrelli, D.; Pacelli, F.; Di Cosmo, M.; Mura, G.; Bettarini, F.; Rosa, F.; de Manzoni, G.; Roviello, F. Gastric Linitis Plastica: Which Role for Surgical Resection? Gastric Cancer 2012, 15, 56–60. [Google Scholar] [CrossRef]
- Xiao, H.; Ma, M.; Xiao, Y.; Ouyang, Y.; Tang, M.; Zhou, K.; Hong, Y.; Tang, B.; Zuo, C. Incomplete Resection and Linitis Plastica Are Factors for Poor Survival after Extended Multiorgan Resection in Gastric Cancer Patients. Sci. Rep. 2017, 7, 15800. [Google Scholar] [CrossRef]
- Song, X.; Shi, Y.; Shi, T.; Liu, B.; Wei, J.; Wang, J. The Efficacy of Treating Patients with Non-Metastatic Gastric Linitis Plastica Using Surgery with Chemotherapy and/or Radiotherapy. Ann. Transl. Med. 2020, 8, 1433. [Google Scholar] [CrossRef]
- Blackham, A.U.; Swords, D.S.; Levine, E.A.; Fino, N.F.; Squires, M.H.; Poultsides, G.; Fields, R.C.; Bloomston, M.; Weber, S.M.; Pawlik, T.M.; et al. Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative. Ann. Surg. Oncol. 2016, 23, 1203–1211. [Google Scholar] [CrossRef]
- Morgant, S.; Artru, P.; Oudjit, A.; Lourenco, N.; Pasquer, A.; Walter, T.; Gornet, J.-M.; Rouquette, A.; Brezault, C.; Coriat, R. Endoscopic Ultrasound Efficacy in Staging Gastric Linitis Plastica Lesion: A Retrospective Multicentric French Study. Ann. Transl. Med. 2021, 9, 50. [Google Scholar] [CrossRef]
- Vivier-Chicoteau, J.; Lambert, J.; Coriat, R.; Bonnot, P.E.; Goere, D.; Roche, B.; Dior, M.; Goujon, G.; Morgant, S.; Pocard, M.; et al. Development and Internal Validation of a Diagnostic Score for Gastric Linitis Plastica. Gastric Cancer 2020, 23, 639–647. [Google Scholar] [CrossRef]
- Morgant, S.; Artru, P.; Oudjit, A.; Lourenco, N.; Pasquer, A.; Walter, T.; Gornet, J.-M.; Rouquette, A.; Lledo, G.; Brezault, C.; et al. Computed Tomography Scan Efficacy in Staging Gastric Linitis Plastica Lesion: A Retrospective Multicentric French Study. Cancer Manag. Res. 2018, 10, 3825–3831. [Google Scholar] [CrossRef] [PubMed]
- Shitara, K.; Lordick, F.; Bang, Y.-J.; Enzinger, P.; Ilson, D.; Shah, M.A.; Van Cutsem, E.; Xu, R.-H.; Aprile, G.; Xu, J.; et al. Zolbetuximab plus MFOLFOX6 in Patients with CLDN18.2-Positive, HER2-Negative, Untreated, Locally Advanced Unresectable or Metastatic Gastric or Gastro-Oesophageal Junction Adenocarcinoma (SPOTLIGHT): A Multicentre, Randomised, Double-Blind, Phase 3 Trial. Lancet 2023, 401, 1655–1668. [Google Scholar] [CrossRef] [PubMed]
- Yamamoto, Y.; Kasashima, H.; Fukui, Y.; Tsujio, G.; Yashiro, M.; Maeda, K. The Heterogeneity of Cancer-Associated Fibroblast Subpopulations: Their Origins, Biomarkers, and Roles in the Tumor Microenvironment. Cancer Sci. 2023, 114, 16–24. [Google Scholar] [CrossRef]
- Chen, Y.; Xu, S.; Huang, C.; Ling, Y.; Liang, C.; Miao, Y.; Sun, X.; Li, Y.; Zhou, Z. Cancer Cells Invasion to the Gastric Bare Area Adipose Tissue: A Poor Prognostic Predictor for Gastric Cancer. World J. Surg. Oncol. 2020, 18, 300. [Google Scholar] [CrossRef] [PubMed]
- Götze, T.O.; Piso, P.; Lorenzen, S.; Bankstahl, U.S.; Pauligk, C.; Elshafei, M.; Amato, G.; Reim, D.; Bechstein, W.O.; Königsrainer, A.; et al. Preventive HIPEC in Combination with Perioperative FLOT versus FLOT Alone for Resectable Diffuse Type Gastric and Gastroesophageal Junction Type II/III Adenocarcinoma—The Phase III “PREVENT”-(FLOT9) Trial of the AIO/CAOGI/ACO. BMC Cancer 2021, 21, 1158. [Google Scholar] [CrossRef] [PubMed]
- Han, Y.; Xuan, Y.; Liu, X.; Zhu, H.; Zhang, M.; Xu, D.; Wang, Y.; Cai, H. Development of a Quantitative Diagnostic Criterion for Gastric Linitis Plastica: Findings From a Large Single-Institutional Study. Front. Oncol. 2021, 11, 683608. [Google Scholar] [CrossRef]
- Kodera, Y.; Takahashi, N.; Yoshikawa, T.; Takiguchi, N.; Fujitani, K.; Ito, Y.; Miyamoto, K.; Takayama, O.; Imano, M.; Kobayashi, D.; et al. Feasibility of Weekly Intraperitoneal versus Intravenous Paclitaxel Therapy Delivered from the Day of Radical Surgery for Gastric Cancer: A Preliminary Safety Analysis of the INPACT Study, a Randomized Controlled Trial. Gastric Cancer 2017, 20, 190–199. [Google Scholar] [CrossRef][Green Version]
- Takahashi, N.; Kanda, M.; Yoshikawa, T.; Takiguchi, N.; Fujitani, K.; Miyamoto, K.; Ito, Y.; Takayama, O.; Imano, M.; Mitsumori, N.; et al. A Randomized Phase II Multicenter Trial to Explore Efficacy of Weekly Intraperitoneal in Comparison with Intravenous Paclitaxel Administered Immediately after Gastrectomy to the Patients with High Risk of Peritoneal Recurrence: Final Results of the INPACT Trial. Gastric Cancer 2018, 21, 1014–1023. [Google Scholar] [CrossRef]
- Ishigami, H.; Tsuji, Y.; Shinohara, H.; Kodera, Y.; Kanda, M.; Yabusaki, H.; Ito, S.; Imano, M.; Yamashita, H.; Hidemura, A.; et al. Intraperitoneal Chemotherapy as Adjuvant or Perioperative Chemotherapy for Patients with Type 4 Scirrhous Gastric Cancer: PHOENIX-GC2 Trial. J. Clin. Med. 2021, 10, 5666. [Google Scholar] [CrossRef]
- Hayashi, T.; Yoshikawa, T.; Sakamaki, K.; Nishikawa, K.; Fujitani, K.; Tanabe, K.; Misawa, K.; Matsui, T.; Miki, A.; Nemoto, H.; et al. Primary Results of a Randomized Two-by-Two Factorial Phase II Trial Comparing Neoadjuvant Chemotherapy with Two and Four Courses of Cisplatin/S-1 and Docetaxel/Cisplatin/S-1 as Neoadjuvant Chemotherapy for Advanced Gastric Cancer. Ann. Gastroenterol. Surg. 2020, 4, 540–548. [Google Scholar] [CrossRef]
- Terashima, M.; Iwasaki, Y.; Mizusawa, J.; Katayama, H.; Nakamura, K.; Katai, H.; Yoshikawa, T.; Ito, Y.; Kaji, M.; Kimura, Y.; et al. Randomized Phase III Trial of Gastrectomy with or without Neoadjuvant S-1 plus Cisplatin for Type 4 or Large Type 3 Gastric Cancer, the Short-Term Safety and Surgical Results: Japan Clinical Oncology Group Study (JCOG0501). Gastric Cancer 2019, 22, 1044–1052. [Google Scholar] [CrossRef] [PubMed]
- Hosoda, K.; Azuma, M.; Katada, C.; Moriya, H.; Mieno, H.; Ishido, K.; Ema, A.; Ushiku, H.; Wada, T.; Washio, M.; et al. A Phase II Study of Neoadjuvant Chemotherapy with Docetaxel, Cisplatin, and S-1, Followed by Gastrectomy with D2 Lymph Node Dissection for High-Risk Advanced Gastric Cancer: Results of the KDOG1001 Trial. Gastric Cancer 2019, 22, 598–606. [Google Scholar] [CrossRef] [PubMed]
- Hosoda, K.; Katada, C.; Ishido, K.; Niihara, M.; Ushiku, H.; Sakuraya, M.; Washio, M.; Wada, T.; Watanabe, A.; Harada, H.; et al. Neoadjuvant Chemotherapy plus Surgery for High-Risk Advanced Gastric Cancer: Long-Term Results of KDOG1001 Trial. Langenbecks Arch. Surg. 2020, 405, 777–785. [Google Scholar] [CrossRef] [PubMed]
- Xiang, X.-S.; Su, Y.; Li, G.-L.; Ma, L.; Zhou, C.-S.; Ma, R.-F. Phase II Study of Preoperative Intra-Arterial Epirubicin, Etoposide, and Oxaliplatin Combined with Oral S-1 Chemotherapy for the Treatment of Borrmann Type 4 Gastric Cancer. J. Gastric Cancer 2020, 20, 395–407. [Google Scholar] [CrossRef]
Genes | Role of the Genes | Frequency |
---|---|---|
Angiopoietin-like 4 (ANGPTL4) | Inhibits endothelial cell migration, angiogenesis, regulatory role in lipid metabolism, metastasis. | |
AOX1 | Encoded aldehyde oxidase—oncogenic role | 30% |
ARHGAP4 | Increases the expression of matrix metalloproteinase 2 and 9 and decreases E-cadherin and Claudin 1 | |
ARID1A | Driver gene | 0–40% |
ASPN | Oncogenic driver or a tumor suppressor gene | |
CD44-IGF1R fusion gene and BORCS5-ETV6 fusion | ||
CD-63 | Correlated with SRC, lymph node metastasis, peritoneal metastasis and tumor progression | |
CDH1 | Encodes E-cadherin | 20–65% |
Claudin 18.2 | Impairs tight junctions | 14.1% in advanced gastric cancers |
C-met gene | HGF receptor | |
c-MYC | ||
DCDC1, GOLGA6L10, and MUC12) | 65% | |
Desmoglein-2 | Down-regulated in diffuse gastric cancer | |
ELK4, MDM4, SLC45A3, H3F3A and ZNF429. | ||
FAK/Src/PI3K-Akt/ERK | Metastasis | |
FAT3, and PTPN14 from the HIPPO pathway | Tumor suppressor pathway | 75% |
FGFR2 | Increase invasion and migration through THBS-1 pathway | >5–10% |
MET | Tyrosine kinase receptor for HGF | |
MMP 7 | Degrade the extracellular matrix and also promotes apoptosis evasion in cancer cells | |
MUC6 | 20% | |
NOS3 | Enhance migration and invasion and peritoneal dissemination | |
OR51B5 | Increases cell survival and collagen biosynthesis | |
p-27 | Cell cycle inhibitor | |
RELN | Driver gene | 75% |
STK11/LKB1 | Tumor suppressor gene | |
TP53/TTN |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Christodoulidis, G.; Koumarelas, K.E.; Kouliou, M.N.; Samara, M.; Thodou, E.; Zacharoulis, D. The Genomic Signatures of Linitis Plastica Signal the Entrance into a New Era: Novel Approaches for Diagnosis and Treatment. Int. J. Mol. Sci. 2023, 24, 14680. https://doi.org/10.3390/ijms241914680
Christodoulidis G, Koumarelas KE, Kouliou MN, Samara M, Thodou E, Zacharoulis D. The Genomic Signatures of Linitis Plastica Signal the Entrance into a New Era: Novel Approaches for Diagnosis and Treatment. International Journal of Molecular Sciences. 2023; 24(19):14680. https://doi.org/10.3390/ijms241914680
Chicago/Turabian StyleChristodoulidis, Grigorios, Konstantinos Eleftherios Koumarelas, Marina Nektaria Kouliou, Maria Samara, Eleni Thodou, and Dimitris Zacharoulis. 2023. "The Genomic Signatures of Linitis Plastica Signal the Entrance into a New Era: Novel Approaches for Diagnosis and Treatment" International Journal of Molecular Sciences 24, no. 19: 14680. https://doi.org/10.3390/ijms241914680
APA StyleChristodoulidis, G., Koumarelas, K. E., Kouliou, M. N., Samara, M., Thodou, E., & Zacharoulis, D. (2023). The Genomic Signatures of Linitis Plastica Signal the Entrance into a New Era: Novel Approaches for Diagnosis and Treatment. International Journal of Molecular Sciences, 24(19), 14680. https://doi.org/10.3390/ijms241914680